InsidersTradesSigma
Track the Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are quoted on CA CA, under the supervision of SEDI. Market capitalisation: €3.1m. The latest transaction was reported on 6 July 2026 (00 - Opening Balance-Initial SEDI Report). Among the most active insiders: Seltenrich, Michelle. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Rakovina Therapeutics Inc., formerly Vincero Capital Corp., is a biotechnology company focused on developing innovative cancer treatments. It is listed on the XTSE.